CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/srep29032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Myoferlin Silencing Inhibits VEGFR2-mediated Proliferation of Metastatic Clear Cell Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2019English

Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma

Cancer Discovery
Oncology
2017English

The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls

2012English

Establishment of an miR‑137‑knockout Cell Model Using CRISPR/Cas9 Genome Editing

Oncology Letters
Cancer ResearchOncology
2018English

Axitinib for the Management of Metastatic Renal Cell Carcinoma

Drugs in R and D
Pharmacology
2011English

Renal Cell Carcinoma Metastatic to the Scalp

Rare Tumors
OncologyHistology
2016English

Review: Updates on Novel Therapies for Metastatic Renal Cell Carcinoma

Therapeutic Advances in Medical Oncology
Oncology
2010English

Subtotal Distal Pancreatectomy for Metachronous Metastatic Renal Clear Cell Carcinoma

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2012English

Patterns of Care for Metastatic Renal Cell Carcinoma in Australia

BJU International
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy